Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-014159
Filing Date
2026-03-31
Accepted
2026-03-31 16:10:35
Documents
71
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 2529127
2 EX-10.69 ex10-69.htm EX-10.69 4212
3 EX-23.1 ex23-1.htm EX-23.1 3827
4 EX-23.2 ex23-2.htm EX-23.2 3361
5 EX-31.1 ex31-1.htm EX-31.1 12149
6 EX-31.2 ex31-2.htm EX-31.2 12543
7 EX-32.1 ex32-1.htm EX-32.1 6816
8 EX-32.2 ex32-2.htm EX-32.2 6665
9 GRAPHIC form10-k_001.jpg GRAPHIC 32378
10 GRAPHIC form10-k_002.jpg GRAPHIC 31387
11 GRAPHIC ex10-69_001.jpg GRAPHIC 251513
12 GRAPHIC ex10-69_002.jpg GRAPHIC 616554
13 GRAPHIC ex10-69_003.jpg GRAPHIC 232249
14 GRAPHIC ex10-69_004.jpg GRAPHIC 361968
15 GRAPHIC ex10-69_005.jpg GRAPHIC 520636
  Complete submission text file 0001493152-26-014159.txt   11098857

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE kapa-20251231.xsd EX-101.SCH 53706
17 XBRL CALCULATION FILE kapa-20251231_cal.xml EX-101.CAL 47362
18 XBRL DEFINITION FILE kapa-20251231_def.xml EX-101.DEF 211184
19 XBRL LABEL FILE kapa-20251231_lab.xml EX-101.LAB 480851
20 XBRL PRESENTATION FILE kapa-20251231_pre.xml EX-101.PRE 354085
74 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 978591
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-42275 | Film No.: 26821834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)